SAE’s Injectable Drug Delivery Conference returns in 2025 as a unique platform for senior technical experts from big pharma to meet and discuss the scientific aspects of parenteral drug delivery, with primary emphasis on biocompatibility, device primary packaging, extractables and leachables, and formulation development.

Attendees can also delve into the latest in drug-device interactions, sustainable materials and regulatory hot-takes, and examine cutting-edge developments within subcutaneous delivery of biologics, peptides and more.

Don’t miss the chance to hear detailed case-studies from high-level big pharma experts and be involved in interactive panel discussions, examining device material selection and adoption of delivery devices for advanced modalities. This focus on technical, in-depth presentations allows for a tailored audience of device developers compared to wide and varied audience of other conferences.

This conference is poised to be a pivotal event for professionals seeking focused discussions on the latest innovations within injectable drug product development and delivery, ensuring attendees are equipped with the latest insights to drive progress in this dynamic field.

Event link here.